Borneol enhances the antidepressant effects of asiaticoside by promoting its distribution into the brain
Tianheng Hou1, Xiaobo Li1, Chongsheng Peng1
1School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, PR China.
Abstract:
Asiaticoside (AS) has antidepressant effects, with poor druggability characterized with inaccessibility into the brain. Here, we assessed AS distribution in the asiaticoside-borneol formula (FAB), with AS administrated orally. High performance liquid chromatography (HPLC) was applied for AS detection. The antidepressant effects of both FAB and AS were evaluated. Rats were subjected to behavioral despair paradigms and chronic unpredictable stress model (CUS) after acute and chronic drug administration, respectively. Hippocampal 5-HT, NE, BDNF, and TNF-α levels were detected, and pathological changes were observed by H&E staining. AS was detected in rat brain tissues after FAB administration, while AS was not detected when administered alone, indicating that borneol (BOR) promoted its distribution into the rat brain. Interestingly, FAB significantly reduced the immobility time in modified forced swimming test (FST) unlike AS used as a single therapy, also reversing sucrose intake more significantly compared with AS. Furthermore, FAB upregulated BDNF and 5-HT more significantly compared with AS, which revealed a possible multi-mechanism of action.
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
07:58Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Anxiolytic Drugs: Benzodiazepines and Buspirone
Drugs Affecting Neurotransmitter Release or Uptake
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
